NM_005514.8:c.*196C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005514.8(HLA-B):c.*196C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0802 in 452,790 control chromosomes in the GnomAD database, including 1,309 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.099 ( 630 hom., cov: 31)
Exomes 𝑓: 0.071 ( 679 hom. )
Consequence
HLA-B
NM_005514.8 3_prime_UTR
NM_005514.8 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.690
Publications
20 publications found
Genes affected
HLA-B (HGNC:4932): (major histocompatibility complex, class I, B) HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0992 AC: 14981AN: 151080Hom.: 630 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14981
AN:
151080
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0707 AC: 21331AN: 301592Hom.: 679 Cov.: 0 AF XY: 0.0671 AC XY: 10662AN XY: 159008 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
21331
AN:
301592
Hom.:
Cov.:
0
AF XY:
AC XY:
10662
AN XY:
159008
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
408
AN:
9462
American (AMR)
AF:
AC:
752
AN:
14000
Ashkenazi Jewish (ASJ)
AF:
AC:
383
AN:
9770
East Asian (EAS)
AF:
AC:
933
AN:
20266
South Asian (SAS)
AF:
AC:
1573
AN:
40412
European-Finnish (FIN)
AF:
AC:
1059
AN:
25668
Middle Eastern (MID)
AF:
AC:
92
AN:
2554
European-Non Finnish (NFE)
AF:
AC:
14779
AN:
162556
Other (OTH)
AF:
AC:
1352
AN:
16904
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.366
Heterozygous variant carriers
0
984
1969
2953
3938
4922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0991 AC: 14984AN: 151198Hom.: 630 Cov.: 31 AF XY: 0.0945 AC XY: 6988AN XY: 73936 show subpopulations
GnomAD4 genome
AF:
AC:
14984
AN:
151198
Hom.:
Cov.:
31
AF XY:
AC XY:
6988
AN XY:
73936
show subpopulations
African (AFR)
AF:
AC:
2641
AN:
41356
American (AMR)
AF:
AC:
1592
AN:
15164
Ashkenazi Jewish (ASJ)
AF:
AC:
225
AN:
3454
East Asian (EAS)
AF:
AC:
132
AN:
5166
South Asian (SAS)
AF:
AC:
395
AN:
4792
European-Finnish (FIN)
AF:
AC:
623
AN:
10548
Middle Eastern (MID)
AF:
AC:
12
AN:
292
European-Non Finnish (NFE)
AF:
AC:
9024
AN:
67428
Other (OTH)
AF:
AC:
206
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.413
Heterozygous variant carriers
0
612
1224
1836
2448
3060
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
200
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.